Diltiazem Hydrochloride: Is It Right for You?
Is It Right for You?
A complete guide to Diltiazem Hydrochloride — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Diltiazem Hydrochloride?
Diltiazem hydrochloride is a benzothiazepine calcium channel blocker (CCB) — a class of cardiovascular drug that acts by blocking L-type voltage-gated calcium channels in cardiac and vascular smooth muscle. It is available in immediate-release tablets (60 mg), modified-release capsules (90 mg, 120 mg, 180 mg, 200 mg, 240 mg, 300 mg, and 360 mg), and topical cream (2%) for anal fissure.
Diltiazem is classified as a non-dihydropyridine calcium channel blocker, placing it in the same subclass as verapamil. Unlike dihydropyridine CCBs (such as amlodipine or nifedipine), diltiazem has significant activity at both cardiac muscle and the sino-atrial and atrioventricular nodes, giving it rate-controlling and antiarrhythmic properties in addition to vasodilatory effects.
Diltiazem hydrochloride is a prescription-only medication in the UK. A licensed clinician must assess your cardiac function, blood pressure, heart rate, and current medications before prescribing.
What Conditions Is Diltiazem Used For?
Diltiazem is indicated for:
prophylaxis and management of stable angina and vasospastic (Prinzmetal's) angina
treatment of mild to moderate hypertension, typically as modified-release preparations
rate control in atrial fibrillation and atrial flutter; acute termination of paroxysmal SVT
2% diltiazem cream is used for chronic anal fissure; smooth muscle relaxation reduces internal anal sphincter tone and promotes fissure healing
Diltiazem effectively reduces angina frequency, controls heart rate, and lowers blood pressure, but does not reverse coronary artery disease, cardiomyopathy, or arrhythmia substrates. Lifestyle modification and disease-modifying therapies (such as statins and antiplatelet agents) remain central to long-term cardiovascular management.
How Does Diltiazem Work?
Calcium ions play a critical role in the electrical activity of the heart and in the contraction of vascular smooth muscle. Diltiazem blocks L-type voltage-gated calcium channels in a frequency- and voltage-dependent manner, inhibiting the inward calcium current during the action potential plateau phase.
Vascular effects — inhibition of calcium entry into vascular smooth muscle causes relaxation and vasodilation of peripheral and coronary arteries, reducing afterload, lowering blood pressure, and increasing coronary blood flow. This reduces myocardial oxygen demand and relieves angina.
Cardiac effects — diltiazem slows conduction through the sino-atrial (SA) and atrio-ventricular (AV) nodes, reducing both the intrinsic heart rate and the rate at which impulses are conducted from the atria to the ventricles. This produces rate control in atrial fibrillation and can terminate re-entrant supraventricular tachycardias.
Topical anal fissure — the 2% cream reduces internal anal sphincter hypertonia by relaxing smooth muscle, improving anodermal blood flow and facilitating fissure healing.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Do not crush or chew modified-release preparations — doing so destroys the controlled-release mechanism and may result in rapid drug release with toxic plasma levels.
Brands of modified-release diltiazem are not interchangeable. The NHS recommends prescribing by brand name to avoid inadvertent dose changes.
Take at consistent times each day to maintain stable plasma levels.
For the topical cream, wash hands before and after application. Apply a small amount (approximately 1 cm ribbon) to the inner anal margin. Avoid contact with eyes.
Monitor your heart rate and blood pressure during treatment, particularly at initiation and following dose increases.
Side Effects of Diltiazem
Most side effects are mild and resolve on their own. Serious side effects are rare but require immediate medical attention.
- Bradycardia (slow heart rate) — particularly at higher doses
- Peripheral oedema (ankle swelling)
- Headache
- Dizziness or light-headedness
- Flushing
- Nausea or dyspepsia
- Fatigue
- Constipation
- Gingival hyperplasia (gum overgrowth) — with long-term use
- Severe bradycardia or heart block — pulse rate below 50 bpm, extreme fatigue, syncope, dizziness
- Acute decompensated heart failure — new or worsening breathlessness, orthopnoea, leg oedema; diltiazem depresses myocardial contractility
- Severe hypotension — lightheadedness, syncope, collapse
- Severe allergic reaction / anaphylaxis — rash, swelling, difficulty breathing
- Serious skin reactions — Stevens-Johnson Syndrome; rare
Diltiazem depresses SA and AV nodal conduction. It is contraindicated in patients with second or third degree AV block, sick sinus syndrome (without pacemaker), or severe bradycardia. Combination with beta-blockers significantly increases the risk of life-threatening conduction disturbance and is generally contraindicated.
Drug Interactions
Always disclose all prescription drugs, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting Diltiazem
diltiazem is a CYP3A4 inhibitor; substantially increases simvastatin levels, increasing the risk of myopathy and rhabdomyolysis. Simvastatin dose should not exceed 20 mg/day with diltiazem.
diltiazem raises ciclosporin plasma levels significantly; monitor drug levels and renal function.
diltiazem increases digoxin levels and further slows AV conduction; risk of digoxin toxicity and profound bradycardia.
CYP3A4 inhibition increases plasma levels; enhanced sedation.
Important Warnings
Diltiazem is absolutely contraindicated in patients with second or third degree AV block (unless a pacemaker is in situ), sick sinus syndrome, or severe left ventricular dysfunction. Its use in conjunction with beta-blockers or amiodarone poses a risk of life-threatening bradycardia or complete heart block.
Diltiazem is contraindicated in patients with acute pulmonary oedema or significantly impaired left ventricular systolic function (ejection fraction <40%). Its negative inotropic effect can precipitate decompensation.
Different modified-release diltiazem formulations have distinct pharmacokinetic profiles. Brand switches should only be made under clinical supervision, with re-titration of dose as required.
Diltiazem is metabolised hepatically; dose adjustment and careful monitoring are required in hepatic impairment. Renal impairment necessitates caution due to accumulation of metabolites.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Diltiazem FAQs
In most circumstances this combination is contraindicated. Both drugs slow the heart rate and AV conduction, and together they risk severe bradycardia, complete heart block, or cardiac failure. This combination should only ever be considered under specialist cardiology supervision with careful monitoring.
Different formulations release diltiazem at different rates, producing different plasma concentration profiles. A switch in brand — even at the same stated dose — can result in either under-treatment or toxic drug levels. Your prescription should always specify the brand name.
The 2% topical cream has very low systemic absorption and is not expected to cause significant cardiovascular effects at the recommended dose. Patients with known cardiac conditions should discuss this with their clinician.
Immediate-release diltiazem provides onset of action within 30–60 minutes. Modified-release formulations provide sustained coverage. Angina frequency typically improves over the first one to two weeks of consistent treatment.
Alcohol and diltiazem can both lower blood pressure; their combination may increase the risk of dizziness, light-headedness, and fainting. Moderate alcohol consumption should be approached cautiously and excessive intake avoided.